RPRD1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.884600E-01
Normal-vs-Stage2
4.387200E-01
Normal-vs-Stage3
1.002120E-02
Normal-vs-Stage4
5.497400E-01
Stage1-vs-Stage2
2.699400E-01
Stage1-vs-Stage3
1.368210E-02
Stage1-vs-Stage4
5.377400E-01
Stage2-vs-Stage3
5.361600E-02
Stage2-vs-Stage4
8.019400E-01
Stage3-vs-Stage4
3.326400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.258400E-01
Normal-vs-AfricanAmerican
7.221400E-01
Normal-vs-Asian
2.978200E-01
Caucasian-vs-AfricanAmerican
2.219800E-01
Caucasian-vs-Asian
3.263600E-01
AfricanAmerican-vs-Asian
1.000630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.007400E-01
Normal-vs-Female
6.647000E-01
Male-vs-Female
6.910600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.744800E-01
Normal-vs-Age(41-60Yrs)
9.501000E-01
Normal-vs-Age(61-80Yrs)
4.926000E-01
Normal-vs-Age(81-100Yrs)
2.505000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.772800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.905000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.041200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.984200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.528200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.709200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.064000E-02
Normal-vs-Daily Drinker
2.836600E-01
Normal-vs-Weekly Drinker
5.713600E-01
Normal-vs-Occasional Drinker
8.776200E-01
Normal-vs-Social Drinker
8.375000E-01
Non Drinker-vs-Daily Drinker
9.377800E-01
Non Drinker-vs-Weekly Drinker
2.292800E-01
Non Drinker-vs-Occasional Drinker
2.689900E-02
Non Drinker-vs-Social Drinker
5.300400E-02
Daily Drinker-vs-Weekly Drinker
3.440000E-01
Daily Drinker-vs-Occasional Drinker
4.279900E-02
Daily Drinker-vs-Social Drinker
5.042400E-02
Weekly Drinker-vs-Occasional Drinker
2.901600E-01
Weekly Drinker-vs-Social Drinker
2.845800E-01
Occasional Drinker-vs-Social Drinker
8.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.593590E-01
Normal-vs-Grade 2
1.386630E-01
Normal-vs-Grade 3
6.569700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.292070E-02
Grade 1-vs-Grade 3
1.207840E-02
Grade 1-vs-Grade 4
1.593590E-01
Grade 2-vs-Grade 3
9.204000E-01
Grade 2-vs-Grade 4
1.386630E-01
Grade 3-vs-Grade 4
6.569700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.020000E-01
Normal-vs-NonDiabetic
7.077600E-01
Diabetic-vs-NonDiabetic
3.768100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.075600E-02
Normal-vs-NoPancreatitis
5.939200E-01
Pancreatitis-vs-NoPancreatitis
2.386400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.960600E-01
Normal-vs-N1
4.887000E-01
N0-vs-N1
4.675400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.217400E-01
Normal-vs-TP53-NonMutant
7.064000E-01
TP53-Mutant-vs-TP53-NonMutant
3.551300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
